Speaker illustration

Doctor Philip D Adamson

University of Otago Christchurch, Christchurch (New Zealand)

Member of:

European Society of Cardiology

Dual antiplatelet therapy to inhibit myocardial injury in patients with high-risk coronary artery plaque: a randomized controlled trial

Event: ESC Congress 2019

Topic: Positron Emission Tomography (PET)

Session: Blockbusters from the Young - Multimodality Imaging in coronary artery disease


Impact of international guidelines' differing approaches to the risk stratification of patients with suspected stable angina: Insights form PROMISE and SCOT-HEART

Event: ESC Congress 2018

Topic: Clinical, Other

Session: Latest registry data on coronary disease outcomes


Prognostic value of convalescent high-sensitivity troponin I concentrations following acute coronary syndrome

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Cardiac troponins: starting levels and outcomes


Diagnostic and prognostic benefits of CTCA using the updated NICE guidance: An analysis of the Scottish computed tomography of the heart (SCOT-HEART) trial

Event: ESC Congress 2017

Topic: Angina pectoris stable

Session: Young Investigator Awards Session Population Sciences


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb